申请人:E.R. Squibb & Sons, Inc.
公开号:EP0163458A1
公开(公告)日:1985-12-04
New compounds, useful for the treatment of hyperten- sion, have the formula
and pharmaceutically acceptable salts thereof, wherein
R, is hydrogen or methyl;
R2 is hydrogen, alkyl, alkanoyl, or arylcarbonyl;
R3 and R4 are each aryl; R3 and R4 are each cycloalkyl; R3 is hydrogen or alkyl and R4 is cycloalkyl or 9H-fluoren-9-yl; or R3 is hydrogen or alkyl and R4 is heteroaryl;
R5 and R6 are the same or different and each is hydrogen, hydroxy, alkoxy or alkanoyl; and
n is 1, 2, 3 and 4.
可用于治疗高血压的新化合物具有如下式及其药学上可接受的盐,其中 R, 是氢或甲基;R2 是氢、烷基、烷酰基或芳羰基;R3 和 R4 各自是芳基;R3 和 R4 各自是环烷基;R3 是氢或烷基,R4 是环烷基或 9H-芴 -9- 基;或 R3 是氢或烷基,R4 是杂芳基;R5 和 R6 相同或不同,各自是氢、羟基、烷氧基或烷酰基;n 是 1、2、3 和 4。